Application of Esketamine in Patients with Traumatic Severe Brain Injury and Analysis of Changes in Serum Neurofactor Levels
Objective:To explore the application of ketamine in patients with traumatic severe cranioce-rebral injury and analyze the changes in serum neurotrophic factor levels.Methods:A total of 180 patients with traumatic severe craniocerebral injury treated in our hospital from January 2020 to January 2023 were se-lected as the research objects and divided into two groups,with 90 cases in each group,according to the ran-dom number table method.The control group received single sufentanil drug treatment after surgery,while the study group received ketamine treatment based on the control group.The pain score,agitation score,cognitive function(MoCA scale),and changes in serum neurotrophic factors(BDNF,NGF)and inflammatory factors(hs-CRP,TNF-α,IL-6)at different time points were observed in both groups.Results:At 12h and 24h af-ter administration,the pain scores and agitation scores in both groups were lower than before administration,and the scores in the study group were lower than those in the control group at 12h and 24h after administra-tion.The MoCA scores in both groups decreased after administration,with the study group higher than the control group.Both BDNF and NGF levels increased after administration in both groups,with the study group higher than the control group.The levels of hs-CRP,TNF-α,and IL-6 decreased in both groups after ad-ministration,with the study group lower than the control group(P<0.05).Conclusion:The application of ketamine in patients with traumatic severe craniocerebral injury can effectively reduce pain and agitation scores,improve cognitive function,promote the generation of neurotrophic factors,and reduce the level of in-flammatory factors.
国家科技期刊平台
NSTL
万方数据
